AHA GUIDELINES Bundle (free trial)

Management of Adults With Congenital Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1541979

Contents of this Issue

Navigation

Page 33 of 93

34 Specific Conditions 4.1.2. Ventricular Septal Defect COR LOE Recommendations Diagnostic 1 B-NR 1. Patients with an unrepaired VSD should be assessed for the presence of PAH to guide decisions about medical therapy and repair. 1 B-NR 2. In adults with a perimembranous VSD being considered for repair, evaluation to exclude RV outflow tract (RVOT) obstruction or double-chambered right ventricle (DCRV) is recommended to improve management planning. 1 C-LD 3. Adults with a VSD (repaired or unrepaired) and PAH should be followed by specialists with expertise in ACHD and pulmonary hypertension to reduce morbidity and mortality. erapeutic 1 B-NR 4. In adults with a VSD, a significant left-to-right shunt (Qp:Qs ≥1.5), and significant or progressive LV dilatation with no evidence of PAH (PVR ≤2 Wood units), closure of the defect is recommended to eliminate the shunt and preserve ventricular function. 2a C-LD 5. In adults with a VSD, LV volume overload, Qp:Qs ≥1.5:1, and mild PAH (PVR >2 but <5 Wood units), closure of the VSD is reasonable to eliminate the shunt, in order to reduce the risk for progressive PAH and the burden of chronic volume overload on the LV. 2a C-LD 6. In adults with an outlet or perimembranous VSD causing progressive moderate or greater aortic regurgitation, closure of the VSD is reasonable to preserve aortic valve function. 2b C-LD 7. In adults with a recent history of infective endocarditis involving a VSD, closure of the VSD may be reasonable to reduce the risk for recurrent endocarditis. 2b C-LD 8. In adults with a VSD, Qp:Qs ≥1.5, and PAH (PVR 5 to 8 Wood units) without hypoxemia, if PVR drops to <5 Wood units with PAH therapies, usefulness of closure of the VSD is uncertain to reduce the risk for progressive PAH and the burden of chronic volume overload on the left ventricle. 3: No Benefit B-NR 9. In adults with a VSD, Qp:Qs <1.5, and no other indications, closure should not be performed to avoid unnecessary perioperative risks. 3: Harm B-NR 10. In adults with a VSD and Eisenmenger physiolog y, VSD closure should not be performed to avoid escalating morbidity and mortality.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Management of Adults With Congenital Heart Disease